213 related articles for article (PubMed ID: 20162572)
1. KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses.
Demokan S; Chang X; Chuang A; Mydlarz WK; Kaur J; Huang P; Khan Z; Khan T; Ostrow KL; Brait M; Hoque MO; Liegeois NJ; Sidransky D; Koch W; Califano JA
Int J Cancer; 2010 Nov; 127(10):2351-9. PubMed ID: 20162572
[TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy.
Pattani KM; Zhang Z; Demokan S; Glazer C; Loyo M; Goodman S; Sidransky D; Bermudez F; Jean-Charles G; McCaffrey T; Padhya T; Phelan J; Spivakovsky S; Bowne HY; Goldberg JD; Rolnitzky L; Robbins M; Kerr AR; Sirois D; Califano JA
Cancer Prev Res (Phila); 2010 Sep; 3(9):1093-103. PubMed ID: 20798208
[TBL] [Abstract][Full Text] [Related]
3. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance.
Carvalho AL; Henrique R; Jeronimo C; Nayak CS; Reddy AN; Hoque MO; Chang S; Brait M; Jiang WW; Kim MM; Claybourne Q; Goldenberg D; Khan Z; Khan T; Westra WH; Sidransky D; Koch W; Califano JA
Clin Cancer Res; 2011 Jul; 17(14):4782-9. PubMed ID: 21628494
[TBL] [Abstract][Full Text] [Related]
4. Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC.
Sun W; Zaboli D; Liu Y; Arnaoutakis D; Khan T; Wang H; Koch W; Khan Z; Califano JA
PLoS One; 2012; 7(3):e33642. PubMed ID: 22438973
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA
Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation in Indian primary oral squamous cell carcinoma.
Kaur J; Demokan S; Tripathi SC; Macha MA; Begum S; Califano JA; Ralhan R
Int J Cancer; 2010 Nov; 127(10):2367-73. PubMed ID: 20473870
[TBL] [Abstract][Full Text] [Related]
7. Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer.
Demokan S; Chuang AY; Pattani KM; Sidransky D; Koch W; Califano JA
Oncol Rep; 2014 Feb; 31(2):1014-20. PubMed ID: 24337411
[TBL] [Abstract][Full Text] [Related]
8. Identification of guanine nucleotide-binding protein γ-7 as an epigenetically silenced gene in head and neck cancer by gene expression profiling.
Demokan S; Chuang AY; Chang X; Khan T; Smith IM; Pattani KM; Dasgupta S; Begum S; Khan Z; Liegeois NJ; Westra WH; Sidransky D; Koch W; Califano JA
Int J Oncol; 2013 Apr; 42(4):1427-36. PubMed ID: 23403885
[TBL] [Abstract][Full Text] [Related]
9. EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions.
Schussel J; Zhou XC; Zhang Z; Pattani K; Bermudez F; Jean-Charles G; McCaffrey T; Padhya T; Phelan J; Spivakovsky S; Brait M; Li R; Bowne HY; Goldberg JD; Rolnitzky L; Robbins M; Kerr AR; Sirois D; Califano JA
Clin Cancer Res; 2013 Jun; 19(12):3268-75. PubMed ID: 23637120
[TBL] [Abstract][Full Text] [Related]
10. Droplet digital PCR of tumor suppressor gene methylation in serial oral rinses of patients with head and neck squamous cell carcinoma.
Fung SYH; Chan KCA; Wong EWY; Ng CWK; Cho R; Yeung ZWC; Lam JWK; Chan JYK
Head Neck; 2021 Jun; 43(6):1812-1822. PubMed ID: 33594807
[TBL] [Abstract][Full Text] [Related]
11. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
[TBL] [Abstract][Full Text] [Related]
12. Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: a cooperative group correlative study.
Roh JL; Wang XV; Manola J; Sidransky D; Forastiere AA; Koch WM
Clin Cancer Res; 2013 May; 19(9):2528-40. PubMed ID: 23444219
[TBL] [Abstract][Full Text] [Related]
13. Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma.
Zhao BJ; Sun DG; Zhang M; Tan SN; Ma X
Dis Esophagus; 2009; 22(1):55-61. PubMed ID: 18564167
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients.
Rettori MM; de Carvalho AC; Bomfim Longo AL; de Oliveira CZ; Kowalski LP; Carvalho AL; Vettore AL
Carcinogenesis; 2013 Jan; 34(1):20-7. PubMed ID: 23042095
[TBL] [Abstract][Full Text] [Related]
15. Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer.
Sun W; Zaboli D; Wang H; Liu Y; Arnaoutakis D; Khan T; Khan Z; Koch WM; Califano JA
Clin Cancer Res; 2012 Feb; 18(4):1082-91. PubMed ID: 22228635
[TBL] [Abstract][Full Text] [Related]
16. Serum biomarkers for detection of head and neck squamous cell carcinoma.
Mydlarz WK; Hennessey PT; Wang H; Carvalho AL; Califano JA
Head Neck; 2016 Jan; 38(1):9-14. PubMed ID: 24995714
[TBL] [Abstract][Full Text] [Related]
17. Novel approaches to global mining of aberrantly methylated promoter sites in squamous head and neck cancer.
Worsham MJ; Chen KM; Stephen JK; Havard S; Benninger MS
Otolaryngol Head Neck Surg; 2010 Jul; 143(1):116-21, 121.e1-19. PubMed ID: 20620629
[TBL] [Abstract][Full Text] [Related]
18. Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV-Positive Oropharyngeal Cancer.
Shen S; Saito Y; Ren S; Liu C; Guo T; Qualliotine J; Khan Z; Sadat S; Califano JA
Otolaryngol Head Neck Surg; 2020 Apr; 162(4):512-519. PubMed ID: 32041482
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer.
Misawa K; Mochizuki D; Imai A; Endo S; Mima M; Misawa Y; Kanazawa T; Carey TE; Mineta H
Oncotarget; 2016 May; 7(18):26087-98. PubMed ID: 27027429
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
